The FDA is telling manufacturers of unapproved cold and allergy medicines containing the antihistamine carbinoxamine to stop making the products. The agency also issued guidelines to clarify its policy on unapproved drugs and its intent to pursue enforcement action for unapproved products. There reportedly are several hundred unapproved drugs contained in thousands of different products sold in the U.S.

Full Story:

Related Summaries